Early lesion formation in colorectal carcinogenesis is associated with adiponectin status whereas neoplastic lesions are associated with diet and sex in C57BL/6J mice

Nutrition and Cancer

Volumn 63, Issue 8, 2011, Pages 1297-1306

  Boddicker, Rebecca L ^a   Whitley, Elizabeth ^a   Birt, Diane F ^a   Spurlock, Michael E ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR; AZOXYMETHANE; DEXTRAN SULFATE; INSULIN RECEPTOR; SATURATED FATTY ACID; TOLL LIKE RECEPTOR 4;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; FEMALE; GENE EXPRESSION; GENOTYPE; HISTOPATHOLOGY; INCIDENCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; SEX DIFFERENCE;

ADIPONECTIN; ANIMALS; AZOXYMETHANE; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; DIET; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INSULIN; RECEPTORS, ADIPONECTIN; RISK FACTORS; SEX FACTORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84857304412     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.606954     Document Type: Article

References (53)

1. Kharroubi I, Rasschaert J, Eizirik DL, and Cnop M: Expression of adiponectin receptors in pancreatic [beta] cells. Biochem Biophysical Res Comm 312, 1118-1122, 2003. (Pubitemid 37490931)
2. Kos K, Wong SPY, Huda MSB, C. akir M, Jernas M, et al. In humans the adiponectin receptor R2 is expressed predominantly in adipose tissue and linked to the adipose tissue expression of MMIF-1. Diabetes Obesity Metab 12, 360-363, 2010.
3. Yoneda K, Tomimoto A, Endo H, Iida H, Sugiyama M, et al. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep 20, 479-483, 2008.
4. Ajuwon KM and Spurlock ME: Adiponectin inhibits LPS-induced NF- {kappa}B acti Nat. Cell Biol.ation and IL-6 production and increases PPAR{gamma}2 expression in adipocytesv Am J Physiol Regul Integr Comp Physiol 288, R1220-R1225, 2005. (Pubitemid 40593705)
5. Tsuchida A, Yamauchi T, Ito Y, Hada Y,Maki T, et al. Insulin/foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279, 30817-30822, 2004. (Pubitemid 38938015)
6. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, et al. The role of lipocalin 2 in the regulation of inflammation in adipocytes andmacrophagesv Mol Endocrinol 22, 1416-1426, 2008. (Pubitemid 351787001)
7. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56, 2533-2540, 2007. (Pubitemid 47523260)
8. Rao Cv, Hirose Y, Indranie C, and Reddy BS:Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61, 1927-1933, 2001.
9. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, et al. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 54, 862-868, 2009.
10. Kitayama J, Tabuchi M, Tsurita G, Ishikawa M, Otani K, et al. Adiposity and gastrointestinal malignancy. Digestion 79, 26-32, 2009.
11. Wei EK, Giovannucci E, Fuchs CS, Willett WC, and Mantzoros CS: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97, 1688-1694, 2005. (Pubitemid 41672235)
12. Lukanova A, Soderberg S, Kaaks R, Jellum E, and Stattin P: Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 15, 401-402, 2006.
13. Ogunwobi OO and Beales ILP: Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regulatory Peptides 134, 105-113, 2006.
14. Williams CJ, Mitsiades N, Sozopoulos E, HsiA,WolkA, et al.Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer 15, 289-299, 2008. (Pubitemid 351449747)
15. Corpet DE, Jacquinet C, Peiffer G, and Taché S: Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 27, 316-320, 1997. (Pubitemid 27161531)
16. Liu S, Baracos v, Quinney H, Le Bricon T, and Clandinin M: Parallel insulin-like growth factor I and insulin resistance in muscles of rats fed a high fat diet. Endocrinology 136, 3318-3324, 1995.
17. Koch T, Briviba K, Watzl B, Bub A, and Barth S: Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia. Eur J Nutr 47, 161-170, 2008. (Pubitemid 351703671)
18. Miyamoto S, Tanaka T, and Murakami A: Increased visceral fat mass and insulin signaling in colitis-related colon carcinogenesis model mice. Chemico-Biol Interact 183, 271-275, 2010.
19. Jaffe T and SchwartzB: Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123, 2543-2556, 2008.
20. Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131, 853-861, 2006. (Pubitemid 44307068)
21. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57, 1531-1538, 2008.
22. Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132, 601-614, 2007. (Pubitemid 46274660)
23. Suzuki R,Kohno H, Sugie S,NakagamaH, and Tanaka T: Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogensis 27, 162-169, 2006. (Pubitemid 43025257)
24. Davis JE, Gabler NK,Walker-Daniels J, and Spurlock ME: Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 16, 1248-1255, 2008. (Pubitemid 351770507)
25. Di Gregorio C, Losi L, Fante R, Modica S, Ghidoni M, et al. Histology of aberrant crypt foci in the human colon. Histopathology 30, 328-334, 1997. (Pubitemid 27168792)
26. Shpitz B, Bomstein Y, Mekori Y, Cohen R, Kaufman Z, et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol 29, 469-475, 1998. (Pubitemid 28213466)
27. Fujisawa THE, Tomimoto A, Sugiyama M, Takahashi H, Saito S, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57, 1531-1538, 2008.
28. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 24, 1441-1452, 2010.
29. Charlton HK,Webster J, Kruger S, Simpson F, Richards AA, et al. ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling. Biochem Biophys Res Comm 392, 234-239, 2010.
30. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8, 516-523, 2006.
31. Heiker JT, Wottawah CM, Juhl C, Kosel D, Morl K, et al. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. Cell Signal 21, 936-942, 2009.
32. Xu Y, Wang N, Ling F, Li P, and Gao Y: Receptor for activated C-kinase 1, a no.el binding partner of adiponectin receptor 1. Biochem Biophys Res Comm 378, 95-98, 2009.
33. Qiu Y, Mao T, Zhang Y, Shao M, You J, et al. A crucial role for RACK1 in the regulation of glucose-stimulated IRE1alpha activation in pancreatic beta cells. Sci Signal 3, ra7, 2010.
34. Ning K, Miller LC, Laidlaw HA, Burgess LA, Perera NM, et al. A no.el leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic [beta]-cells. EMBO J 25, 2377-2387, 2006. (Pubitemid 44012221)
35. Mamidipudi ., Dhillon NK, Parman T, Miller LD, Lee KC, et al. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints. Oncogene 26, 2914-2924, 2006. (Pubitemid 46701439)
36. Izeradjene K, Douglas L, Delaney A, and Houghton JA: Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell linesv 24, 2050-2058, 2005. (Pubitemid 40516198)
37. Gro.e KL, Fried SK, Greenberg AS, Xiao XQ, and Clegg DJ: A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int J Obes 34, 989-1000, 2010.
38. Priego T, Sanchez J, Pico C, and Palou A: Sex-differential expression of metabolism-related genes in response to a high-fat diet. Obesity 16, 819-826, 2008. (Pubitemid 351465638)
39. Koo JH and Leong RW: Sex differences in epidemiological, clinical, and pathological characteristics of colorectal cancer. J Gastroenterol Hepat 25, 33-42, 2009.
40. Ealey KN and Archer MC: Ele.ated circulating adiponectin and ele.ated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. Int J Cancer 124, 2226-2230, 2009.
41. Weige CC, Allred KF, and Allred CD: Estradiol Alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res 69, 9118-9124, 2009.
42. .erdu EF, Deng Y, Bercik P, and Collins SM: Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest liver Physiol 283, G27-G36, 2002. (Pubitemid 34666159)
43. Rim SH, Seeff L, Ahmed F, King JB, and Coughlin SS: Colorectal cancer incidence in the United States, 1999-2004. Cancer 115, 1967-1976, 2009.
44. Bullen JW Jr., Bluher S, Kelesidis T, and Mantzoros CS: Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292, E1079-E1086, 2007. (Pubitemid 46536507)
45. Gnagnarella P, Gandini S, La .ecchia C, and Maisonneu.e P: Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87, 1793-1801, 2008. (Pubitemid 351872644)
46. Nakamura T, Ishikawa H, Takeyama I, Kawano A, Ishiguro S, et al. Excessive fat restriction might promote the recurrence of colorectal tumors. Nutr Cancer 62, 154-163, 2010.
47. ZhangW, ThorntonWHJr., andMacDonald RS: Insulin-like growth factor- I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. J Nutr 128, 158-165, 1998. (Pubitemid 28124980)
48. Kiunga GA, Raju J, Sabljic N, Bajaj G, Good CK, et al. Ele.ated insulin receptor protein expression in experimentally induced colonic tumors. Cancer Lett 211, 145-153, 2004. (Pubitemid 38824628)
49. Jaffe T and SchwartzB: Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123, 2543-2556, 2008.
50. Guadagni F, Roselli M, Martini F, Spila A, Riondino S, et al. Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 29, 3321-3327, 2009.
51. Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57, 268-273, 2008.
52. Fenton JI,Birmingham JM, Hursting SD, andHord NG: Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer 122, 2437-2445, 2008. (Pubitemid 351590475)
53. Otake S, Takeda H, Fujishima S, Fukui T, Orii T, et al. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol 16, 1252-1257, 2010.